The core concept is the Insurance Risk Charge, a capital loading designed to cover the risk that insurance liabilities prove higher than their best estimate values. It is composed of three pillars:

Insurance Liability Risk Charge (ILRC) covers deviations in the value of existing liabilities. It consists of:

• Outstanding Claims Risk Charge: a risk margin applied to outstanding claims (excluding claims settled but not yet paid). The margin is the lesser of 1.03 × (hospital treatment SEUs)^(‑0.16) and 0.34. For a small fund with, say, 10,000 SEUs, the formula gives 1.03 × (10,000)^(‑0.16) ≈ 0.47, which is capped at 0.34. This cap means the margin never exceeds 34 per cent of outstanding claims. For a very large fund with 1 million SEUs, the margin is about 0.22 (or 22 per cent).
• Premiums Liability Risk Charge (PLRC): applies to the premiums liability (unearned premium) of health insurance business (HIB) and health‑related insurance business (HRIB). For HIB, the stress percentage = 22.1% - 1.2% × log(HT SEUs) + an additional uncertainty stress of 0.33 × (min(max(growth over recent 12 months, 2.5%), 15%) - 2.5%). This extra term penalises rapid premium growth. If growth is below 2.5% per annum, the additional stress is zero. For HRIB, the stress percentage = 37.9% - 1.2% × log(12‑month accrued premium). These formulas embed economies of scale: larger funds (more SEUs or higher premium) get a smaller stress percentage, while smaller funds face higher charges.
• Risk Equalisation Risk Charge: a flat 4 per cent of the “unbilled calculated deficit” , the amount the insurer would have to pay into the risk equalisation pool if each SEU received the average calculated deficit amount, for periods where the levy has accrued but not yet been invoiced by APRA.
• Other Insurance Liabilities Risk Charge: the excess of a 99.5 per cent value‑at‑risk estimate over the central estimate of other insurance liabilities (e.g. liability adequacy provisions not captured elsewhere).

Future Exposure Risk Charge (FER) covers the risk that the next twelve months’ financial performance (benefits, expenses, premiums) will be materially worse than expected. For HIB, the FER is the loss from combining an Adverse Event Stress (25% immediate lapse of all policies where the policyholder is under 65, with the calculated deficit per SEU increased by 20% to reflect worsened risk equalisation) and a Prescribed Benefit Stress (an additional across‑the‑board increase in benefits and expenses by the HIB stress percentage). For HRIB, only the Prescribed Benefit Stress applies (at the HRIB stress percentage). FER is calculated net of reinsurance, with no allowance for investment income. Cash flows may be discounted using CGS yields. Management actions (e.g. changing coverage, closing products) can reduce the loss but cannot be assumed to occur within nine months, and any insurance profit after management actions cannot offset the stressed loss (the FER has a minimum of zero for each component).

Deferred Claims Liability Risk Charge (DCLRC) covers the tail risk in deferred claims (claims incurred but not yet reported). It is the difference between the deferred claims liability at 99.5 per cent sufficiency and the best estimate, reduced by an aggregation benefit formula that recognises partial diversification with other components: DCL aggregation benefit = (D + O) - sqrt(D² + O² + 2 × 0.20 × D × O), where D is the standalone shock to deferred claims and O is the sum of all other IRC components.

Single Equivalent Unit (SEU) is the exposure measure used in the size‑based formulas. “Hospital treatment SEUs” are the number of single equivalent units for hospital treatment, as defined in the risk equalisation rules. The term “calculated deficit” refers to the average amount payable per SEU under the Private Health Insurance (Risk Equalisation Policy) Rules 2015.

Management actions are subject to strict restrictions: they cannot commence within nine months of the reporting date, must respect contractual guarantees and legislative notice periods (including s 93‑20 of the PHI Act requiring reasonable notice before product changes), and cannot generate positive insurance profits that reduce the FER below zero.

The standard applies separately to each fund, so an insurer with multiple health benefits funds (e.g. a “hospital fund” and an “extras fund”) must calculate the IRC for each, and also for its general fund. The term “private health insurer” means the whole entity, but “fund” means each individual fund.

The primary entities affected are all private health insurers registered under the Act. The standard applies to each health benefits fund and the general fund separately, so an insurer operating several funds (e.g. separate hospital, general treatment, and ambulance funds) must run the calculation multiple times. The compliance burden falls heaviest on smaller insurers with fewer than, say, 50,000 SEUs. They face higher stress percentages in the Premiums Liability Risk Charge (because 22.1% - 1.2% × log(SEUs) is larger when SEUs are small) and may be closer to the 34 per cent cap on the Outstanding Claims Risk Margin. The growth‑related additional uncertainty stress in the HIB stress formula also hits small, fast‑growing funds disproportionately: a fund growing SEUs by 15 per cent per annum faces an extra 4.13 percentage points on top of the size stress, compared with zero for funds with growth below 2.5 per cent.

Insurers with younger member bases are particularly exposed to the Adverse Event Stress in the FER, which assumes a 25 per cent lapse of all policies where the policyholder is under 65. If an insurer’s under‑65 block is large and profitable, the stress will generate a significant loss. The stress also increases the calculated deficit per SEU by 20 per cent, which amplifies the risk equalisation outflow shock.

Internal actuaries must perform the calculations, source the data (SEUs, growth rates, accrued premiums, risk equalisation data, liability estimates from HPS 340), and document assumptions about management actions, discount rates, and the 99.5 per cent sufficiency estimates. The standard does not prescribe a model for the 99.5 per cent quantile; it requires the insurer’s own assessment, which introduces subjectivity and potential for dispute with APRA.

APRA itself is affected: it must review compliance, exercise its discretion to adjust or exclude requirements where appropriate, and potentially issue directions if an insurer’s IRC is inadequate or incorrectly calculated. The standard also affects reinsurers indirectly, because the FER is calculated net of reinsurance, so the terms of reinsurance treaties directly influence the size of the charge.

Policyholders are ultimately affected through the capital costs passed on in premiums. Higher capital requirements for small insurers or those with volatile growth can increase premium prices or reduce product availability.

The Risk Equalisation pool administrator is indirectly affected because the Risk Equalisation Risk Charge requires data on “unbilled calculated deficit” , amounts that the insurer would have had to pay if each SEU drew the average calculated deficit. This charge does not require an actual invoice from the risk equalisation pool; it is based on a hypothetical calculation, which adds compliance work.

Duties:

1. A private health insurer must calculate the IRC for each fund separately, using the methods and formulas prescribed in paragraphs 1 to 39, applied to the fund’s own data. It must not average or offset charges across funds.
2. The insurer must apply the Outstanding Claims Risk Margin formula on outstanding claims (excluding settled but not paid) using the fund’s hospital treatment SEUs.
3. For the Premiums Liability Risk Charge, it must compute the HIB Stress % which includes both the size stress and the additional uncertainty stress based on the growth in hospital treatment SEUs over the most recent 12, 12-24, and 24-36 month periods. When a merger has occurred, growth must be calculated on the merged entity’s total SEUs so that only organic growth is captured, not acquisition‑driven growth.
4. The Risk Equalisation Risk Charge must be calculated using the “unbilled calculated deficit” metric. The insurer must estimate what it would have been required to pay into the risk equalisation pool over the period up to the reporting date for which the levy has accrued but not yet been invoiced by APRA, using the average calculated deficit per SEU as defined in rule 11(1)(e) of the Private Health Insurance (Risk Equalisation Policy) Rules 2015.
5. For the Other Insurance Liabilities Risk Charge and the Deferred Claims Liability Risk Charge, the insurer must determine the 99.5 per cent sufficiency level based on its own assessment, and then compute the charge as the excess of that level over the central estimate, adjusted for the DCL aggregation benefit.
6. The FER must be calculated for the 12 months from the reporting date, stressing benefits incurred, other business expenses, and accrued premium for both HIB and HRIB. The stresses are the Adverse Event Stress and the Prescribed Benefit Stress. The insurer must apply them “net of any reinsurance arrangements” and with no allowance for investment income except discounting at CGS yields.
7. Management actions may be assumed but only after a minimum nine‑month delay from the reporting date. Any contractual guarantees must be respected. The insurer must also allow sufficient time to inform policyholders of changes as required by s 93‑20 of the PHI Act (reasonable time before the change takes effect). After management actions are applied, any forecast insurance profits cannot be used to reduce the FER below zero.
8. The insurer must not incorporate any tax benefits into any component of the IRC. Tax benefits are dealt with separately under HPS 110.
9. All calculations must be performed in compliance with HPS 340 for the liability values and HPS 110 for the overall capital requirement.

Rights:

1. The insurer may apply to APRA for a written adjustment or exclusion of a specific requirement. APRA has the discretion to grant or refuse such an adjustment.
2. The insurer can choose to discount the FER cash flows using CGS yields at the relevant durations. It is not mandatory but permitted.
3. The insurer can make its own assumptions about the 99.5 per cent sufficiency level for other insurance liabilities and deferred claims liability, provided it documents the basis.
4. The insurer may avail itself of the DCL aggregation benefit formula, which reduces the Deferred Claims Liability Risk Charge to reflect partial diversification with other IRC components, assuming a 20 per cent correlation.
5. Management actions can be customised to the insurer’s specific circumstances, subject to the restrictions in paragraphs 28-33.

The prudential standard itself does not prescribe penalties; it is made under s 92(1) of the Act, and a failure to comply with a prudential standard is a contravention of the Act. The Act empowers APRA to take a range of enforcement actions: issue a direction to comply, impose additional capital requirements, apply conditions to an insurer’s licence, or refer the matter to the Federal Court for civil penalty proceedings. Civil penalties under the PHIPS Act can be substantial (the source does not provide specific amounts, but comparable APRA‑administered legislation carries penalties of up to 10,000 penalty units for bodies corporate, adjusted periodically). APRA may also issue a notice under paragraph 39 of this standard, adjusting or excluding a specific requirement. This power can be used both to relieve an insurer from a rule and to impose a stricter requirement in lieu. An insurer that does not comply with an APRA direction may face further enforcement, including licence suspension or cancellation. The standard also notes that “Previous exercise of discretion” under a previous version continues to have effect, but that does not insulate the insurer from enforcement for non‑compliance with the new standard. Enforcement risk is heightened by the complexity of the formulas: errors in the growth calculation, the SEU count, or the 99.5 per cent sufficiency assessment could lead to a materially understated IRC, exposing the insurer to regulatory action. The standard does not provide a safe harbour for actuarial judgment; the insurer bears the risk that APRA will challenge the assumptions used.

This prudential standard sits within the hierarchy of the Private Health Insurance (Prudential Supervision) Act 2015 and the prudential standards framework. It directly references Prudential Standard HPS 340 Insurance Liability Valuation as the source for the values of outstanding claims liabilities, premiums liabilities, risk equalisation assets or liabilities, other insurance liabilities, and deferred claims liabilities. The IRC is then calculated on top of those values. It also references Prudential Standard HPS 110 Capital Adequacy, which prescribes the prescribed capital amount; the IRC feeds into that amount, but tax benefits from the IRC must be excluded from the IRC itself and may instead be applied at the HPS 110 level. The standard also interacts with the Private Health Insurance (Risk Equalisation Policy) Rules 2015, specifically rule 11(1)(d) and (e) which define the “calculated deficit” and “average calculated deficit” per SEU used in the Adverse Event Stress and the Risk Equalisation Risk Charge. The Private Health Insurance Act 2007 (PHI Act) is engaged through s 93‑20, which requires notice to insured persons of proposed changes a reasonable time before the change takes effect. Management actions that involve product changes must comply with this notice requirement, and the nine‑month minimum delay may need to be extended to accommodate it. The Insurance Act 1973 (if applicable) or other general insurance legislation does not apply directly, but insurers that also write non‑health insurance may need to reconcile this standard with other APRA requirements at the entity level. The standard defines terms by reference to Prudential Standard CPS 001 Defined Terms, which consolidates definitions across APRA’s prudential framework. Finally, the standard notes that an exercise of APRA’s discretion under a previous version continues to have effect as if exercised under the corresponding power in this version, which provides transitional continuity but does not relieve an insurer from complying with new requirements.

The source text does not provide a dedicated amendment history, but internal evidence indicates that this standard is a new version that supersedes an earlier one. Paragraph 40 states: “An exercise of APRA’s discretion (such as an approval, waiver or direction) under a previous version of this Prudential Standard continues to have effect as though exercised pursuant to a corresponding power (if any) exercisable by APRA under this Prudential Standard.” This confirms that a previous version existed. No dates of earlier amendments are provided, nor are the changes between versions described. The standard applies from 1 January 2026, implying it was made in 2024 or 2025. Without access to the earlier version or supporting materials, it is impossible to detail what changed. Practitioners should compare this version with the previous HPS 112 (likely titled something similar) to identify revisions. Likely changes include the introduction of the growth‑based additional uncertainty stress in the Premiums Liability Risk Charge (which was not present in earlier stress formulas) and the more detailed Management Action restrictions. The 9‑month delay and the prohibition on offsetting insurance profits after management actions appear strict relative to industry practice. The DCL aggregation benefit formula is also new; earlier versions may have simply summed component charges without the diversification adjustment. The Outstanding Claims Risk Margin cap of 0.34 may have replaced a formula‑only approach. Insurers relying on previous discretions from APRA should confirm that those discretions remain valid under the new standard. APRA may have issued a covering letter or explanatory statement with the new standard; that would be the best source of amendment history.

The source text contains no reference to litigation. There is no mention of any court cases, tribunal decisions, or APRA‑approved frameworks that have been challenged. This is unsurprising for a prudential standard that is technical and prescriptive. However, the industry context is that private health insurers have previously litigated against APRA over capital requirements (e.g., Judicial Review under the ADJR Act), though none is referenced here. The formulas in this standard, particularly the use of SEU‑based size stress and the growth adjustment, may be open to challenge if an insurer believes they are arbitrary or discriminatory. The 20 per cent correlation assumption in the DCL aggregation benefit is a fixed parameter, not calibrated to any actual portfolio; an insurer might argue it materially understates or overstates diversification, but the standard does permit APRA to adjust or exclude requirements, providing a mechanism short of litigation. Any challenge would likely focus on the reasonableness of the stress parameters or the failure of APRA to consider an insurer’s specific risk profile. The lack of litigation history in the source is not surprising; prudential standards are rarely litigated because the cost and regulatory risk of challenging APRA are high. Insurers generally seek relief through the written adjustment process in paragraph 39 rather than through the courts. Nonetheless, practitioners should be aware that the ground is fertile for dispute if APRA applies the standard rigidly, and that the standard itself is silent on appeal rights.

Several traps in the standard can catch insurers off guard:

1. Growth‑related stress triggers automatically for any growth above 2.5% per annum. The additional uncertainty stress is 33 per cent of (min(max(growth, 2.5%), 15%) - 2.5%), so even a 3 per cent growth rate adds 0.165 percentage points to the HIB stress percentage. Many insurers may not monitor trailing three‑year growth as defined here; growth is measured over three overlapping 12‑month windows (t, t‑1, t‑2), and the maximum growth over those periods is used (capped at 15%). A single spike year from a merger or product campaign can increase the charge for years afterwards if growth persists.

2. The Outstanding Claims Risk Margin cap of 0.34. The formula 1.03 × SEUs^(‑0.16) produces values exceeding 0.34 only when SEUs are below approximately 1,800. For most funds with any meaningful size, the cap is not binding. The trap is that the cap may create a discontinuity: a fund with 1,800 SEUs gets a margin of 0.34, while a fund with 1,900 SEUs gets 1.03 × (1900)^(‑0.16) ≈ 0.333, which is below the cap. This is a relatively minor issue, but for very small insurers the cap is effectively binding.

3. The “unbilled calculated deficit” in the Risk Equalisation Risk Charge is a hypothetical amount. It is not the actual levy invoiced but what the insurer would have paid if each SEU attracted the average deficit. This means the charge can be larger than the actual cash exposure if the insurer’s risk equalisation position is favourable (e.g., if it has many older policyholders and receives net inflows). The charge is levied regardless of whether the insurer is a net payer or recipient.

4. No allowance for investment income in the FER. The standard explicitly says “there is no allowance for investment income or other parts of the business other than discounting.” This forces insurers to assume that stressed losses are not offset by investment returns, which may be conservative. It also means that insurers with large investment portfolios cannot use them to reduce the FER.

5. Management actions cannot assume profit offset. After management actions are applied, “any estimated insurance profits on HIB or HRIB cannot be used to reduce the FER.” So if management actions turn a loss into a profit on a stressed basis, the FER is zero for that component, but the profit cannot reduce the FER of the other component. Each component has a floor of zero.

6. The nine‑month delay for management actions starts from the reporting date, not from the stress event. This is a very long period: an insurer cannot assume any management response for the first three‑quarters of the projection year. Since the FER projects for exactly 12 months, management actions are effectively limited to the last quarter (and only if the nine‑month period is not extended for notification times under s 93‑20). The extension for notification could push the start of management actions beyond the 12‑month horizon, making them unusable.

7. Merger treatment in the growth calculation. Where a merger has occurred since t‑2, the growth rates must be calculated on the total HT SEUs of the merged entity, with the aim of capturing “only organic growth.” This is ambiguous: how to decompose growth into organic vs. acquisition components? The standard assumes the insurer can cleanly strip out merger effects. In practice, this may require pro‑forma historical SEU data for the combined entity before the merger.

8. The correlation assumption of 20 per cent in the DCL aggregation benefit is fixed. It does not vary by fund or line of business. For a fund where deferred claims are highly correlated with other liabilities (e.g., because both depend on claims inflation), a higher correlation would be more appropriate; the fixed 20 per cent may overstate the diversification benefit.

9. Tax benefits cannot be included in the IRC but can be used elsewhere. This means insurers cannot reduce the IRC for the tax deductibility of claims or expenses. The standard notes that tax benefits may reduce the prescribed capital amount under HPS 110, but that is a separate calculation. A failure to separately track tax benefits could lead to double‑counting or missing them.

10. Application per fund separately. An insurer cannot net charges across funds. If one fund is loss‑making and another is profitable, the insurer still must hold capital for the loss‑making fund; the profits of the other fund do not reduce the IRC of the first.

Compliance with HPS 112 requires a systematic, documented process that integrates with the insurer’s existing actuarial, risk management, and financial reporting functions. The following steps provide a practical approach:

1. Data gathering. Obtain for each fund: outstanding claims liabilities (excluding settled but not yet paid) per HPS 340; premiums liabilities per HPS 340; other insurance liabilities per HPS 340; deferred claims liability per HPS 340; hospital treatment SEUs at the reporting date; total health insurance business accrued premium for the 12 months ending on the reporting date; health‑related insurance business accrued premium for the same period; the calculated deficit per SEU as per the risk equalisation rules; and historical HT SEU data for the prior three years to calculate growth rates.

2. Calculate the Outstanding Claims Risk Margin using the formula min(1.03 × (HT SEUs)^(‑0.16), 0.34). Multiply by outstanding claims (excluding settled but not yet paid). This yields the Outstanding Claims Risk Charge.

3. Calculate the Premiums Liability Risk Charge. For HIB: compute HIB Stress % = 22.1% - 1.2% × log(HT SEUs) + additional uncertainty stress (0.33 × (min(max(growth_recent, 2.5%), 15%) - 2.5%)), where growth_recent is the maximum of (growth_t, growth_(t‑1), growth_(t‑2)). Multiply HIB Stress % by the HIB premiums liability. For HRIB: compute HRIB Stress % = 37.9% - 1.2% × log(HRIB 12‑month accrued premium). Multiply by the HRIB premiums liability. Sum the two results.

4. Calculate the Risk Equalisation Risk Charge as 4% of the unbilled calculated deficit. The insurer must estimate the amount it would have paid into risk equalisation for the period up to the reporting date for which the levy has accrued but not yet been invoiced, using the average calculated deficit per SEU. Document the methodology.

5. Calculate the Other Insurance Liabilities Risk Charge as the excess of the 99.5% quantile estimate over the central estimate of other insurance liabilities. The insurer must have a validated model or approach to determine the 99.5% sufficiency level. This will often require stochastic modelling or stress testing.

6. Calculate the Deferred Claims Liability Risk Charge as the 99.5% quantile of deferred claims liability minus the central estimate, then subtract the DCL aggregation benefit. Compute D = (DCL at 99.5%) - (DCL central). Let O = ILRC + FER (both excluding the DCL component). Then DCL aggregation benefit = (D + O) - sqrt(D² + O² + 2 × 0.20 × D × O). The DCLRC = D - benefit. Note that “O” here includes the FER, so the FER must be calculated before the DCLRC.

7. Calculate the FER. For HIB: project 12 months of benefits incurred, other business expenses, and accrued premium. Apply the Adverse Event Stress: lapse 25% of policies with policyholder under 65 immediately; reduce lapsed premiums and claims using average age‑cohort values; increase the calculated deficit per SEU by 20%. Then add the Prescribed Benefit Stress: increase the stressed benefits and expenses by the HIB Stress % from step 3. Discount the net cash flow (benefits + expenses - premium) to the reporting date using CGS yields. The result, if negative, is the FER_HIB; if positive, set to zero. For HRIB: project 12 months and apply only the Prescribed Benefit Stress using HRIB Stress % from step 3; discount and floor at zero. Sum FER_HIB and FER_HRIB.

8. Consider management actions. If the insurer wishes to assume management actions in the FER, document each action, the timeframe (cannot begin before nine months, extended for notification), and ensure the actions do not breach contractual guarantees or legislative notice periods. After implementing management actions, recalculate the FER, but any resulting profit cannot offset losses; each component remains floored at zero.

9. Sum the components for each fund: ILRC (sum of steps 2 through 5) + FER (step 7) + DCLRC (step 6). This is the fund‑level IRC. Repeat for each health benefits fund and the general fund.

10. Document all assumptions, data sources, and calculations. Maintain records of the SEU counts, growth rates, the basis for the 99.5% sufficiency estimates, management action justifications, and discount rates. Ensure that no tax benefits are included in any IRC component. The insurer should also reconcile the IRC with the capital requirement under HPS 110 and report to APRA as required.

11. If the insurer believes a specific requirement is inappropriate, it may apply to APRA for a written adjustment or exclusion. This request should include a detailed justification and alternative methodology. APRA’s decision is discretionary.

12. Review compliance with the transition provision. Any discretion exercised under the previous version continues in effect; ensure that such discretions are still relevant under the new standard and that they correspond to a power in this version.